Abstract
Background: Throughout history, menopause has been regarded as a transition in a woman’s life. With the increase in life expectancy, women now spend more than a third of their lives in menopause. During these years, women may experience intolerable symptoms both physically and mentally, leading them to seek clinical advice. It is imperative for healthcare providers to improve the quality of life by reducing bothersome menopausal symptoms and preventing disorders such as osteoporosis and atherosclerosis. The current treatment in the form of hormone replacement therapy (HRT) is sometimes inadequate with several limitations and adverse effects. Objective and rationale: The current review aims to discuss the need, efficacy, and limitations of current HRT; the role of other ovarian hormones, and where we stand in comparison with ovary-in situ; and finally, explore towards the preparation of an HRT model by regeneration of ovaries tissues through stem cells which can replicate a functional ovary. Search methods: Four electronic databases (MEDLINE, Embase, Web of Science and CINAHL) were searched from database inception until 26 April 2018, using a combination of relevant controlled vocabulary terms and free-text terms related to ‘menopause’, ‘hormone replacement therapy’, ‘ovary regeneration’, ‘stem cells’ and ‘ovarian transplantation’. Outcomes: We present a synthesis of the existing data on the efficacy and limitations of HRT. HRT is far from adequate in postmenopausal women with symptoms of hormone deprivation as it fails to deliver all hormones secreted by naïve ovarian tissue. Moreover, the pharmacokinetics of synthetic hormones makes them substantially different from natural ones. Not only does the number and type of hormones given in HRT matter, but the route of delivering and their release in circulation are also imperative. The hormones are delivered either orally or topically in a non-physiological uniform manner, which brings along with it several side effects. These identify the need for a hormone delivery system which replicates, integrates and reacts as per the requirement of the female body. Wider implications: The review outlines the strengths and weaknesses of HRT and highlights the potential areas for future research. There is a tremendous potential for research in this field to understand the collective roles of the various ovarian hormones and to devise an auto-regulated hormone delivery system which replicates the normal physiology. Its clinical applications can prove to be transformative for postmenopausal women helping them to lead a healthy and productive life.
Highlights
Throughout history, menopause has been regarded as a transition in a woman’s life
It is notable that hormone replacement therapy (HRT) appears to decrease the risk of diabetes mellitus type 2; the impact is insufficient for HRT to be recommended for its prevention [35,36]
RThTe [c9o4n]te.ntRioencreenmtasintsu: dies have why does oestrogen in HRT increase the risk of Venous Thromboembolism (VTE) while the presence of a functioning ovary does reported anhota?zard ratio of 1.24 to 2.74 in current users after 2 to 5 years of HRT use, which increases further with increasing duration of use [95,96]
Summary
Bthaceksgeryoeuanrds, women experience intolerable symptoms and seek clinical advice. It is imperative for healthTcharroeugphroouvtihdiestrosryt,omiemnoppraouvsee hthasebeqeunarleitgyarodfedliavseasmbayjorretrdaunsciitniogn ibnoathweormsoamn’es limfee. Horomwoenveerr,eapqlauceesmtioenntthtahteirsaypeyt (tHo RbeT)d,ewtehrmicihneisdpisr:im“Iasrtihlye abgaeseodf noantuersatrlogen and pmroegnoesptaeursoenae,mhaarskebreoefnhpeareltshcrainbdedagoinvge?r”dTehceaodnesseftoorf tmheentorpeaautmseehnatsobfepenosctomnseindoerpeaduassaal nsyidmepaltoms, time to introduce preventative strategies to improve the longevity and quality of postmenopausal and hwaosmbeene’ns lqivueess. Lceadteraallg-ecause mortaaltitnya[tu2–ra4l].mTehneorpeaiussae dhaescrbeeaesnedfopurnedvatolebneceasosfoacitahteedrowsciltehropsleisntaynodfcbaerndeifoitvsa, sincuclluadrienvgelnotnsgienvwityomen with alantde raegdeuacetdnaatlul-craaul sme emnoorptaaluitsye [[25––49].].TMheorereiosvaer,dtehcreeraeseadrepsroemvaelenadcediotfioantahlerboesncleefirotssi,ssuancdh as a substcaanrtdiaiolviansccruelaasreevinenthtseinbownoemdeennwsiittyh laantedacgoenastenqautuenratllymaenroedpauucsteio[n5–i9n].tMheorineocvidere,ntcheeroefaorestseoompeorosis and fraadcdtiutiroensa[l1b0e,1n1ef]i.tsN, esuvcehrtahselaessus,bisttacnotmiael sinactreaacsoesitnotfheinbcorneaesdeednrsiistyk aonfdbcreoanssteq[1u2e]n,tolyvaarrieadnu[c3t,i1o3n] and in the incidence of osteoporosis and fractures [10,11]. It comes at a cost of increased risk endomofebtrreiaalst[1[142]]c,aonvcaerriasn. H[3o,1w3]evanedr, eunndliokmeeatrfiualn[c1t4io] ncaanl coevras.ryH, othweeveexro,guennliokuesahfournmctoionneasl, ooveasrtyro, gtheen and progeesxtoegreonnoeu,sphroersmcroinbeesd, odeustrrionggenthaendpopsrtomgeesnteorponaeu,sparlepscerribioedd dinurainsgtetrheeoptyosptemdenmoapnaunsearl tpoerrieopdleinte the functaiosnteinregotoyfpiendsmituanonverartoy rberpilnegteatlhoenfgunscetvioenrianlgsiodfeinesffiteuctosv. ary bring along several side effects
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
